These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8654804)
1. Nucleoside spiroxiranes as suicide inhibitors of the human immunodeficiency virus. Bailey JM; Nelson KA Biochem Soc Trans; 1995 Nov; 23(4):619S. PubMed ID: 8654804 [No Abstract] [Full Text] [Related]
2. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of α-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents. Keane SJ; Ford A; Mullins ND; Maguire NM; Legigan T; Balzarini J; Maguire AR J Org Chem; 2015 Mar; 80(5):2479-93. PubMed ID: 25532055 [TBL] [Abstract][Full Text] [Related]
4. Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues. El-Sayed WA; El-Essawy FA; Ali OM; Nasr BS; Abdalla MM; Abdel-Rahman AA Z Naturforsch C J Biosci; 2009; 64(11-12):773-8. PubMed ID: 20158144 [TBL] [Abstract][Full Text] [Related]
5. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors. Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595 [TBL] [Abstract][Full Text] [Related]
6. Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity. de Castro S; Lobatón E; Pérez-Pérez MJ; San-Félix A; Cordeiro A; Andrei G; Snoeck R; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S J Med Chem; 2005 Feb; 48(4):1158-68. PubMed ID: 15715482 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides. Zhang HW; Detorio M; Herman BD; Solomon S; Bassit L; Nettles JH; Obikhod A; Tao SJ; Mellors JW; Sluis-Cremer N; Coats SJ; Schinazi RF Eur J Med Chem; 2011 Sep; 46(9):3832-44. PubMed ID: 21700368 [TBL] [Abstract][Full Text] [Related]
8. Correlation of molecular conformation and activity of reverse transcriptase inhibitors. Van Roey P; Taylor EW; Chu CK; Schinazi RF Ann N Y Acad Sci; 1990; 616():29-40. PubMed ID: 1706572 [No Abstract] [Full Text] [Related]
9. Synthesis and biological evaluation of phosphonated dihydroisoxazole nucleosides. Romeo G; Iannazzo D; Piperno A; Romeo R; Saglimbeni M; Chiacchio MA; Balestrieri E; Macchi B; Mastino A Bioorg Med Chem; 2006 Jun; 14(11):3818-24. PubMed ID: 16480883 [TBL] [Abstract][Full Text] [Related]
10. Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents. Lee K; Chu CK Antimicrob Agents Chemother; 2001 Jan; 45(1):138-44. PubMed ID: 11120956 [TBL] [Abstract][Full Text] [Related]
11. Nucleoside analogs with vinyl fluoride structure; synthesis and anti-HIV activity. Nakayama T; Asai T; Okazoe T; Suga A; Morizawa Y; Yasuda A Nucleic Acids Symp Ser; 1991; (25):191-2. PubMed ID: 1842079 [No Abstract] [Full Text] [Related]
12. Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties. Maslova AA; Matyugina ES; Snoeck R; Andrei G; Kochetkov SN; Khandazhinskaya AL; Novikov MS Molecules; 2020 Jul; 25(15):. PubMed ID: 32717979 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of 2'-Deoxy-2'-Spirodiflurocyclopropyl Nucleoside Analogs. Liu X; Xia X; Sun C; Lin C; Zhou Y; Hussain M; Tang F; Liu L; Li X; Zhang J Nucleosides Nucleotides Nucleic Acids; 2016 Sep; 35(9):479-94. PubMed ID: 27556785 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV-1 activity of novel TSAO-T derivatives modified at the 2'- and 5'-positions of the sugar moiety. Ingate S; Pérez-Pérez MJ; De Clercq E; Balzarini J; Camarasa MJ Antiviral Res; 1995 Jun; 27(3):281-99. PubMed ID: 8540750 [TBL] [Abstract][Full Text] [Related]
15. Understanding the mode of action of L-nucleosides as antiviral agents: a molecular modeling approach. Lee K; Chong Y; Chu CK Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):385-8. PubMed ID: 11563052 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors. Agarwal HK; Chhikara BS; Doncel GF; Parang K Bioorg Med Chem Lett; 2017 May; 27(9):1934-1937. PubMed ID: 28351588 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 and HSV-1 virus activities of some new polycyclic nucleoside pyrene candidates. Khalifa NM; Al-Omar MA; Amr Ael-G; Haiba ME Int J Biol Macromol; 2013 Mar; 54():51-6. PubMed ID: 23178400 [TBL] [Abstract][Full Text] [Related]
19. Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives. Chamorro C; Pérez-Pérez MJ; Rodríguez-Barrios F; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ Antiviral Res; 2001 Jun; 50(3):207-22. PubMed ID: 11397508 [TBL] [Abstract][Full Text] [Related]